Fibrillary Astrocytoma

✓ A 29-year-old man presented in 1984 with a recent onset of partial seizures marked by speech arrest. Electroencephalography identified a left frontotemporal dysrhythmia. Computerized tomography (CT) scanning revealed a superficial hypodense nonenhancing lesion in the midleft frontal convexity, with some remodeling of the overlying skull. The patient was transferred to the London Health Sciences Centre for subtotal resection of what was diagnosed as a “fibrillary astrocytoma (microcystic).” He received no chemotherapy or radiation therapy and remained well for 11 years.The patient presented again in late 1995 with progressive seizure activity. Both CT and magnetic resonance imaging demonstrated a recurrent enhancing partly cystic lesion. A Grade IV astrocytoma was resected, and within the malignant tumor was a superficial area reminiscent of a dysembryoplastic neuroepithelial tumor (DNT). Data on the lesion that had been resected in 1984 were reviewed, and in retrospect the lesion was identified as a DNT of the complex form. It was bordered by cortical dysplasia and contained glial nodules, in addition to the specific glioneuronal element. The glial nodules were significant for moderate pleomorphism and rare mitotic figures. The Ki67 labeling index averaged 0.3% in the glial nodules and up to 4% focally. Cells were rarely Ki67 positive within the glioneuronal component. This case is the first documented example of malignant transformation of a DNT. It serves as a warning of the potential for malignant transformation in this entity, which has been traditionally accepted as benign. This warning may be especially warranted when confronted with complex forms of DNT. The completeness of resection in the benign state is of paramount importance.

Download Full-text

Fibrillary Astrocytoma

Encyclopedia of Clinical Neuropsychology ◽

10.1007/978-3-319-56782-2_109-2 ◽

2017 ◽

pp. 1-3

Author(s):

Jennifer Tinker

Keyword(s):

Fibrillary Astrocytoma

Download Full-text

Spinal cord astrocytoma: pathological and treatment considerations

Journal of Neurosurgery ◽

10.3171/jns.1995.83.4.0590 ◽

1995 ◽

Vol 83 (4) ◽

pp. 590-595 ◽

Cited By ~ 142

Author(s):

Kern J. Minehan ◽

Edward G. Shaw ◽

Bernd W. Scheithauer ◽

Dean L. Davis ◽

Burton M. Onofrio

Keyword(s):

Spinal Cord ◽

Radiation Therapy ◽

Survival Rate ◽

Pilocytic Astrocytoma ◽

Histological Type ◽

Postoperative Radiation ◽

Postoperative Radiation Therapy ◽

Content Type ◽

Fibrillary Astrocytoma ◽

Fine Print

✓ Seventy-nine patients underwent surgery, with or without radiation therapy, for astrocytoma of the spinal cord. There were 43 tumors (54%) classified as pilocytic astrocytoma and 25 (32%) as diffuse fibrillary astrocytoma. Eleven tumors (14%) could not be classified other than as astrocytoma, “type not otherwise specified.” The 10-year overall survival rate for all 79 patients was 50% but significantly differed by histological type: 81% for patients with pilocytic astrocytoma compared to 15% for those with diffuse fibrillary astrocytoma. Tumor grade by the Kernohan, et al., or St. Anne—Mayo methods was also a significant predictor of survival in patients with diffuse fibrillary astrocytoma. The extent of surgical resection (biopsy vs. subtotal resection vs. gross total resection) did not significantly impact survival among patients with pilocytic or nonpilocytic astrocytomas of the spinal cord, although there was a trend toward poorer survival in patients undergoing some degree of resection as opposed to biopsy. Postoperative radiation therapy improved survival but did so more for diffuse fibrillary astrocytoma than pilocytic astrocytoma. In this series, histological type was the most significant predictor of survival in patients with astrocytoma of the spinal cord. The survival rate was highest in patients who underwent biopsy followed by postoperative radiation therapy.

Download Full-text

BT-4 The treatment history of long-term survivors of Optic Pathway Glioma in Kobe Children’s Hospital

Neuro-Oncology Advances ◽

10.1093/noajnl/vdab159.104 ◽

2021 ◽

Vol 3 (Supplement_6) ◽

pp. vi27-vi27

Author(s):

Atsufumi Kawamura ◽

Junji Koyama ◽

Nobuyuki Akutsu ◽

Masashi Higashino ◽

Kenji Fujita

Keyword(s):

Treatment Plan ◽

Continuous Treatment ◽

Optic Pathway Glioma ◽

Optic Pathway ◽

Children's Hospital ◽

Fibrillary Astrocytoma ◽

Children’S Hospital ◽

History Of ◽

Long Term Survivors

Abstract Optic pathway glioma(OPG) is almost recognized in childhood and about 0.01–0.02% of whole brain tumor in Japan. Because of the rare tumor, there are few reports about results of its treatment. In 2021, Guideline of Optic pathway/hypothalamic glioma is indicated from The japan Society for Neuro-Oncology. We retrospectively study 9 cases history of OPG who have treated for more than 5 years from January 2005 to March 2021 in Kobe Children’s Hospital. Cases are 4 boys and 5 girls. Average age at diagnosis is 3.8 years old and average follow up term is 11 years 10 months. They are 4 Pilocytic astrocytoma, 3 Pilomyxoid astrocytoma, and 1 Fibrillary astrocytoma. Al l cases have survived. There are only 2 cases who could be controlled with single series of surgical treatment and chemotherapy. Most cases need several times of resection and chemotherapy and uncontrollable 5 cases required radiological treatment. 2 cases are still under treatment for over 10 years. For OPG, partial resection to control hydrocephalus is recommended and several trial of chemotherapy must be carried out. There exist a few cases who need continuous treatment for long term. The other side, a few cases are uncontrollable those need radiotherapy to manage tumor volume. Because the history of OPG would be long term, we should adjust the treatment plan to environment of patients.

Download Full-text

Childhood Fibrillary Astrocytoma

10.32388/4awmmq ◽

2020 ◽

Author(s):

Keyword(s):

Fibrillary Astrocytoma

Download Full-text

Fibrillary Astrocytoma

Encyclopedia of Radiation Oncology ◽

10.1007/978-3-540-85516-3_1123 ◽

2013 ◽

pp. 284-284

Author(s):

Patrizia Guerrieri ◽

Paolo Montemaggi ◽

Bradley J. Huth ◽

Claus Roedel ◽

Bradley J. Huth ◽

...

Keyword(s):

Fibrillary Astrocytoma

Download Full-text

Brain Stem Glioma Causing Failure to Thrive

PEDIATRICS ◽

10.1542/peds.47.2.451 ◽

1971 ◽

Vol 47 (2) ◽

pp. 451-455

Author(s):

Robert L. Sieben ◽

Nobuyoshi Ishii

Keyword(s):

Brain Stem ◽

Aspiration Pneumonia ◽

Failure To Thrive ◽

Brain Stem Glioma ◽

Fibrillary Astrocytoma ◽

Bulbar Palsy ◽

The Brain

A small fibrillary astrocytoma of the brain stem led to bulbar palsy, persistent regurgitation, and death from aspiration pneumonia in a 4-month-old boy. As no changes were produced in the external configuration of the brain stem, a pneumoencephalogram might not have revealed the presence of the tumor.

Download Full-text

Concomitant intraventricular colloid cyst and low-grade astrocytoma of the brainstem in a 16-year-old boy

Journal of Neurosurgery Pediatrics ◽

10.3171/2011.7.peds11179 ◽

2011 ◽

Vol 8 (4) ◽

pp. 342-345 ◽

Cited By ~ 3

Author(s):

Abbas Amirjamshidi ◽

Rouzbeh Shams Amiri ◽

Maysam Alimohamadi ◽

Kazem Abbassioun

Keyword(s):

Brain Tumors ◽

Third Ventricle ◽

Treatment Strategies ◽

Colloid Cyst ◽

Special Treatment ◽

Low Grade ◽

Predisposing Factor ◽

Fibrillary Astrocytoma ◽

Different Types ◽

Clinical Awareness

Multiple primary brain tumors are commonly observed in patients with a history of brain radiation therapy or neurofibromatosis. The concomitant presence of 2 different types of brain tumors in a single location or chamber is a very rare clinical presentation in the absence of such a predisposing factor. The authors report on the case of a 16-year-old boy presenting with different types of brain tumors in 2 ventricular chambers concomitantly. This boy had a medium-sized colloid cyst of the third ventricle and a large fibrillary astrocytoma fungating from the brainstem into the floor of the fourth ventricle. The lesions were successfully excised in 2 separate surgeries. Radiotherapy was used as the adjuvant mode of therapy. There has been no sign of tumor recurrence after 16 months of follow-up. Clinical awareness and recognition of such a combination of tumors is important because they will dictate special treatment strategies depending on the individual biological aggressiveness of each tumor.

Download Full-text